Francesca Carlino

HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study

Francesca Carlino, Anna Diana, Anna Ventriglia et al. · Cancers · 2022 · 36 citations · Full text

Medicine, Endocrinology, Oncology +16

Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania ‘Luigi Vanvitelli’

L. Poliero, Pietro Paolo Vitiello, Davide Ciardiello et al. · ESMO Open · 2020 · 22 citations · Full text

Medicine, Oncology, Pathology +17

Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation

Piera Grisolia, Rossella Tufano, Clara Iannarone et al. · Journal of Translational Medicine · 2024 · 15 citations · Full text

Medicine, Genetics, Oncology +17

Genomic Profile and BRCA-1 Promoter Methylation Status in BRCA Mutated Ovarian Cancer: New Insights in Predictive Biomarkers of Olaparib Response

E. Franzese, Sara Centonze, Anna Diana et al. · Frontiers in Oncology · 2019 · 14 citations · Full text

Medicine, Genetics, Oncology +17

Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis

Anna Diana, Francesca Carlino, Giuseppe Buono et al. · Frontiers in Oncology · 2022 · 13 citations · Full text

Medicine, Endocrinology, Oncology +10